Search results for "tolerance"

showing 10 items of 956 documents

Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients

2009

AIM: To investigate the efficacy and safety of cape-citabine plus irinotecan ± bevacizumab in advanced or metastatic colorectal cancer patients. METHODS: Forty six patients with previously untreated, locally-advanced or metastatic colorectal cancer (mCRC) were recruited between 2001-2006 in a prospective open-label phase II trial, in German community-based outpatient clinics. Patients received a standard capecitabine plus irinotecan (CAPIRI) or CAPIRI plus bevacizumab (CAPIRI-BEV) regimen every 3 wk. Dose reductions were mandatory from the first cycle in cases of > grade 2 toxicity. The treatment choice of bevacizumab was at the discretion of the physician. The primary endpoints were respon…

OncologyAdultMalemedicine.medical_specialtyBevacizumabgenetic structuresColorectal cancereducationKaplan-Meier EstimateAntibodies Monoclonal HumanizedGastroenterologyDeoxycytidineDisease-Free SurvivalCapecitabineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineOutpatient clinicHumansProspective StudiesAgedAged 80 and overbusiness.industryGastroenterologyAntibodies MonoclonalGeneral MedicineDrug ToleranceMiddle Agedmedicine.diseasePrimary tumordigestive system diseaseseye diseasesIrinotecanBrief ArticlesBevacizumabRegimenFluorouracilCamptothecinFemaleFluorouracilbusinessColorectal Neoplasmsgeographic locationsmedicine.drug
researchProduct

Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilities.

2015

The introduction of small molecule BRAFV600 kinase inhibitors represents a milestone in the targeted therapy of patients with metastatic melanoma by a significant increase in therapeutic efficacy in terms of overall and progression-free survival compared with conventional chemotherapy. Beside BRAFV600 inhibitor treatment, radiotherapy is a further mainstay for the therapy of metastatic melanoma and thus a concomitant or sequential application of BRAFV600 inhibitors and radiotherapy is inevitable. Recent reports show a significant radiosensitization of the irradiated healthy tissue in patients with melanoma after the combination of radiotherapy and BRAFV600 inhibitors, evoking concern in cl…

OncologyProto-Oncogene Proteins B-rafCancer Researchmedicine.medical_specialtyBRAF inhibitormedicine.medical_treatmentRadiation ToleranceTargeted therapy030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinemedicineCombined Modality TherapyHumansVemurafenibneoplasmsMelanomaProtein Kinase Inhibitorsbusiness.industryMelanomaDabrafenibGeneral Medicinemedicine.diseaseCombined Modality TherapyRadiation therapyOncology030220 oncology & carcinogenesisConcomitantMutationbusinessmedicine.drugFuture oncology (London, England)
researchProduct

Pegylated interferon therapy in chronic hepatitis C: lights and shadows of an innovative treatment

2007

Abstract Pegylated interferon (PEG-IFN) in combination with ribavirin is the standard of treatment for chronic hepatitis C. Several viral and host factors influence the outcome of treatment, such as hepatitis C virus (HCV) genotype, baseline viral load, viral kinetics, race, body weight, advanced liver disease, HIV co-infection, and adherence to therapy. Monitoring the response of HCV to treatment during the early time points (4 weeks or 12 weeks) after initiation of therapy has emerged as a critical tool to predict sustained virologic response (SVR), defined as undetectable serum HCV RNA 24 weeks after the end of therapy. To counterbalance the influence of host and viral factors, treatment…

Oncologymedicine.medical_specialtyHepatitis C virusHuman leukocyte antigenInterferon alpha-2medicine.disease_causeAntiviral AgentsPolyethylene GlycolsLiver diseasechemistry.chemical_compoundChronic hepatitisPegylated interferonInternal medicineRibavirinmedicineHumansHepatologybusiness.industryRibavirinGastroenterologyInterferon-alphavirus diseasesDrug ToleranceHepatitis C Chronicmedicine.diseaseRecombinant ProteinsBlack or African AmericanTreatment OutcomechemistryVirologic responseImmunologybusinessViral loadmedicine.drugDigestive and Liver Disease
researchProduct

Radiation Response of OFDR Distributed Sensors Based on Microstructured Pure Silica Optical Fibers

2015

International audience; Temperature sensors based on microstructured pure silica optical fibers are investigated by OFDR and RIA performed during X-ray irradiation up to 50kGy dose. The results evidence that the temperature measures are poorly influenced by irradiation (the error being less than 0.3°C). Such a radiation tolerance is relevant for the use of these Rayleigh based sensors in harsh environments.

Optical fiberMaterials scienceRadiationOptical fiber sensorbusiness.industryOptical fiber sensorsRadiationRayleigh scatteringTemperature measurementlaw.invention[SPI.TRON]Engineering Sciences [physics]/Electronics[SPI]Engineering Sciences [physics]symbols.namesakeOpticsRadiation tolerancelawsymbolsOptoelectronicsIrradiationElectroniqueElectrical and Electronic EngineeringRayleigh scatteringbusinessRadiation response
researchProduct

Heat tolerance and outdoor temperature in early life, among Italian migrants in Turin–Italy

2009

Outdoor temperatureHeat toleranceGeographySocioeconomicsEarly lifeDemographyIOP Conference Series: Earth and Environmental Science
researchProduct

Robust Output-Feedback Based Fault-Tolerant Control of Active Suspension with Finite-Frequency Constraint ★ ★This work is partly supported by Nationa…

2015

Abstract In this paper, the H∞ fault-tolerant control (FTC) problem of active suspensions with finite-frequency constraints is investigated. A full-car model is employed in the controller design such that the heave, pitch and roll motions can be simultaneously controlled. Both the actuator faults and external disturbance are considered in the controller design. As the human body is more sensitive to the vertical vibration in 4-8Hz, robust H∞ control with finite frequency constraints is designed. From the practical perspective, a robust dynamic output-feedback controller with fault tolerant ability is proposed, while other performances such as suspension deflection and actuator saturation ar…

Output feedbackController designEngineeringbusiness.industryVertical vibrationFault toleranceControl engineeringActive suspensionActuator saturationControl and Systems EngineeringControl theoryDeflection (engineering)businessActuatorIFAC-PapersOnLine
researchProduct

Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells.

2010

Abstract Cross-presentation of soluble Ag on MHC class I molecules to naive CD8 T cells by liver sinusoidal endothelial cells (LSECs) leads to induction of T cell tolerance that requires interaction between coinhibitory B7-H1 on LSECs and programmed cell death-1 on CD8 T cells. In this study, we investigate whether cross-presentation of high as well as low Ag concentrations allowed for LSEC-induced tolerance. Ag concentration directly correlated with the cross-presentation capacity of murine LSECs and thus strength of TCR stimulation. Although LSEC cross-presentation at low-Ag concentrations resulted in tolerance, they induced differentiation into effector T cells (CTL) at high-Ag concentra…

OvalbuminT cellImmunologychemical and pharmacologic phenomenaMice TransgenicCD8-Positive T-LymphocytesLymphocyte ActivationResting Phase Cell CycleMiceCross-PrimingAntigenMHC class ImedicineImmune ToleranceImmunology and AllergyCytotoxic T cellAnimalsCells CulturedMice KnockoutAntigen PresentationbiologyT-cell receptorEndothelial CellsCytotoxicity Tests ImmunologicCoculture TechniquesCell biologyMice Inbred C57BLTolerance inductionCTL*medicine.anatomical_structureLiverbiology.proteinCD80Journal of immunology (Baltimore, Md. : 1950)
researchProduct

MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate

2019

Polo-like kinase (PLK1) has been identified as a potential target for cancer treatment. Although a number of small molecules have been investigated as PLK1 inhibitors, many of which showed limited selectivity. PLK1 harbors a regulatory domain, the Polo box domain (PBD), which has a key regulatory function for kinase activity and substrate recognition. We report on 3-bromomethyl-benzofuran-2-carboxylic acid ethyl ester (designated: MCC1019) as selective PLK1 inhibitor targeting PLK1 PBD. Cytotoxicity and fluorescence polarization-based screening were applied to a library of 1162 drug-like compounds to identify potential inhibitors of PLK1 PBD. The activity of compound MC1019 against the PLK1…

PBD Polo box domainMTD maximal tolerance doseCDC25 cell division cycle 25HIF-1α hypoxia-inducible factor 1 αMST microscale thermophoresisIC50 50% inhibition concentrationMFP M phase promoting factorPARP-1 poly(ADP-ribose) polymerase-10302 clinical medicineFOXO forkhead box ONec-1 necrostatin 1CDC2 cell division cycle protein 2 homologGeneral Pharmacology Toxicology and PharmaceuticsMitotic catastropheCDK cyclin-dependent kinase0303 health sciencesChemistryPolo-like kinaseMono-targeted therapyCell cycleBUBR1 budding uninhibited by benzimidazole-related 1Polo box domain030220 oncology & carcinogenesisPLK1 Polo-like kinaseNecroptosisSpindle damagePLK1IHC immunohistochemistryOriginal articleNecroptosisCell cyclePLK1APC/C anaphase-promoting complex/cyclosomePLK3ABC avidin-biotin complexPI propidium iodide03 medical and health sciencesFBS fetal bovine serumPDB Protein Data BankKd the dissociation constantKinase activity030304 developmental biologyAkt/PKB signaling pathwayCell growthlcsh:RM1-950LC3 light chain 3lcsh:Therapeutics. PharmacologyCancer researchDAPKs death-associated protein kinase3-MA 3-methyladenineDAPI 4′6-diamidino-2-phenylindoleSAC spindle assembly checkpointActa Pharmaceutica Sinica B
researchProduct

Immunoreactivity of Roach,Rutilus rutilus,Following Laboratory Exposure to Bleached Pulp and Paper Mill Effluents

1998

Abstract In order to study immunomodulation, controlled laboratory experiments were carried out with roach ( Rutilus rutilus ) exposed to bleached kraft mill effluent (BKME) or spent bleach liquor (SBL) from two pulp and paper mills using elementary chlorine and chlorine dioxide for bleaching. The total number of immunoglobulin-secreting cells (ISC) and the number of specific antibody-secreting cells (ASC) were determined by ELISPOT assay. Exposure to BKME resulted in decreased numbers of ISC in the spleen. To study the capability of response against foreign antigens the fish were immunized with bovine γ-globulin. Exposure to BKME or SBL reduced antigen-specific ASC response in fish. Moreov…

PaperBleachHealth Toxicology and MutagenesisCyprinidaeImmunoglobulinsIndustrial Wastechemistry.chemical_elementengineering.materialchemistry.chemical_compoundImmune ToleranceChlorineCyprinidaeAnimalsFood scienceChlorine dioxidebiologybusiness.industryEcologyPulp (paper)Public Health Environmental and Occupational HealthOxidesPaper millGeneral Medicinebiology.organism_classificationPollutionchemistryToxicityengineeringChlorineRutilusChlorine CompoundsbusinessSpleenWater Pollutants ChemicalDisinfectantsEcotoxicology and Environmental Safety
researchProduct

The global village of celiac disease

2004

In the last years our knowledge on epidemiology of celiac disease has increased: there is a wide spectrum of its clinical presentation (classical, atypical, silent and latent forms of celiac disease), and of its pathological mucosal intestinal features, which range from early and mild pictures to severe villous atrophy (Marsh stages). In addition, a strong genetic component, associated with the susceptibility to the disease (HLA and non HLA genes), has been found. This knowledge, together with the availability of new high sensitive and specific serological tests (antigliadin, antiendomysium and antitransglutaminase antibodies), has led us to the realization that celiac disease is the most c…

Pathologymedicine.medical_specialtyPediatricsHepatologybusiness.industryGastroenterologynutritional and metabolic diseasesGluten intoleranceHuman leukocyte antigenDiseasemedicine.diseaseSerologyFood intoleranceCeliac DiseaseEpidemiologymedicineHumansbusinessPathologicalEpidemiology.Global Village (American radio show)Digestive and Liver Disease
researchProduct